Letter: The ethics of using inferior regimens in H. pylori randomised trials

Alimentary Pharmacology and Therapeutics

Volumn 35, Issue 7, 2012, Pages 852-854

  Graham, D Y ^a   Fischbach, L A ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; METRONIDAZOLE; PROTON PUMP INHIBITOR;

ANTIBIOTIC RESISTANCE; CHILD CARE; CLINICAL RESEARCH; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG MARKETING; DRUG SAFETY; ERADICATION THERAPY; GASTROINTESTINAL DISEASE; HELICOBACTER INFECTION; HUMAN; KOREA; LETTER; MEDICAL ETHICS; PATIENT CARE; POPULATION RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; SAMPLE SIZE; UNITED STATES; WELFARE;

ANTI-BACTERIAL AGENTS; FEMALE; HELICOBACTER INFECTIONS; HUMANS; MALE; PROTON PUMP INHIBITORS;

EID: 84858188583     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2011.04944.x     Document Type: Letter

References (19)

1. Kim YS, Kim SJ, Yoon JH, et al,. Randomised clinical trial: the efficacy of a 10-day sequential therapy vs. a 14-day standard proton pump inhibitor-based triple therapy for Helicobacter pylori in Korea. Aliment Pharmacol Ther 2011; 34: 1098-105.
2. Oh JH, Dong MS, Choi MG, et al,. Effects of CYP2C19 and MDR1 genotype on the eradication rate of Helicobacter pylori infection by triple therapy with pantoprazole, amoxycillin and clarithromycin. J Gastroenterol Hepatol 2009; 24: 294-8.
3. Choi WH, Park DI, Oh SJ, et al,. Effectiveness of 10 day-sequential therapy for Helicobacter pylori eradication in Korea. Korean J Gastroenterol 2008; 51: 280-4.
4. Kim CG, Song HJ, Kook MC, et al,. Preoperative versus postoperative Helicobacter pylori eradication therapy in gastric cancer patients: a randomized trial. Am J Gastroenterol 2008; 103: 48-54.
5. Kim HW, Kim GH, Cheong JY, et al,. H. pylori eradication: a randomized prospective study of triple therapy with or without ecabet sodium. World J Gastroenterol 2008; 14: 908-12. (Pubitemid 351325030)
6. Kim SY, Lee SW, Jung SW, et al,. Comparative study of Helicobacter pylori eradication rates of twice-versus four-times-daily amoxicillin administered with proton pump inhibitor and clarithromycin: a randomized study. Helicobacter 2008; 13: 282-7.
7. Kim BG, Lee DH, Ye BD, et al,. Comparison of 7-day and 14-day proton pump inhibitor-containing triple therapy for Helicobacter pylori eradication: neither treatment duration provides acceptable eradication rate in Korea. Helicobacter 2007; 12: 31-5. (Pubitemid 46105916)
8. Choi HS, Park DI, Hwang SJ, et al,. Double-dose, new-generation proton pump inhibitors do not improve Helicobacter pylori eradication rate. Helicobacter 2007; 12: 638-42. (Pubitemid 350132069)
9. Graham DY,. Helicobacter pylori eradication therapy research: ethical issues and description of results. Clin Gastroenterol Hepatol 2010; 8: 1032-6.
10. Freedman B,. Equipoise and the ethics of clinical research. N Engl J Med 1987; 317: 141-5. (Pubitemid 17092151)
11. Tremaine WJ,. Equipoise, H. pylori, and Musketeers-choosing an appropriate standard clinical care regimen. Helicobacter 2008; 13: 79-80. (Pubitemid 351347665)
12. Miller FG, Brody H,. A critique of clinical equipoise. Therapeutic misconception in the ethics of clinical trials. Hastings Cent Rep 2003; 33: 19-28.
13. Graham DY, Dore MP,. Helicobacter pylori therapy demystified. Helicobacter 2011; 16: 343-5.
14. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 2000; 284: 3043-5.
15. Ellenberg SS, Temple R,. Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 2: practical issues and specific cases. Ann Intern Med 2000; 133: 464-70.
16. Prieto-Jimenez CA, Cardenas VM, Fischbach LA, et al,. Double-blind randomized trial of quadruple sequential Helicobacter pylori eradication therapy in asymptomatic infected children in El Paso, Texas. J Pediatr Gastroenterol Nutr 2011; 52: 319-25.
17. Cardenas VM, Prieto-Jimenez CA, Mulla ZD, et al,. Helicobacter pylori eradication and change in markers of iron stores among non-iron-deficient children in El Paso, Texas: an etiologic intervention study. J Pediatr Gastroenterol Nutr 2011; 52: 326-32.
18. Gold BD, Colletti RB, Abbott M, et al,. Helicobacter pylori infection in children: recommendations for diagnosis and treatment. J Pediatr Gastroenterol Nutr 2000; 31: 490-7.
19. Redlinger T, O'Rourke K, Goodman KJ,. Age distribution of Helicobacter pylori seroprevalence among young children in a United States/Mexico border community: evidence for transitory infection. Am J Epidemiol 1999; 150: 225-30. (Pubitemid 29344947)